Skip to content

Clinical trials

Recruiting Small Cell Lung Carcinoma trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Small Cell Lung Carcinoma Status: Recruiting Country / region: Germany Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20151
20201
20232
20243
20259
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting21

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim3
AIO-Studien-gGmbH2
AbbVie2
Amgen2
BioNTech SE1
Bristol-Myers Squibb1
Daiichi Sankyo1
GlaxoSmithKline1
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Small Cell Lung Carcinoma21
Lung Neoplasms5
Carcinoma, Non-Small-Cell Lung3
Breast Neoplasms2
Carcinoma, Small Cell1
Colorectal Neoplasms1
Disease1
Endometrial Neoplasms1
Gallbladder Neoplasms1
Head and Neck Neoplasms1

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.